Skip to content

Clinical trials

Completed Adenocarcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Completed Country / region: United States Clear all

156 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20022
20035
20044
20058
20068
20079
20087
200910
201014
201113
201210
20135
201413
20153
20167
20178
20187
20193
20202
20213
20225
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed156

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
M.D. Anderson Cancer Center7
Memorial Sloan Kettering Cancer Center7
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins7
H. Lee Moffitt Cancer Center and Research Institute6
Novartis Pharmaceuticals6
Eli Lilly and Company4
Stanford University4
Celgene3
Mayo Clinic3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma156
Neoplasms46
Pancreatic Neoplasms38
Carcinoma, Non-Small-Cell Lung30
Neoplasm Metastasis26
Lung Neoplasms24
Carcinoma23
Colorectal Neoplasms15
Carcinoma, Squamous Cell14
Prostatic Neoplasms14

Trials

Showing 1 to 25 of 156. Each trial links to its page on Pharma Observatory.

56 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.